Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Performance

Retractable Technologies stock opened at $0.90 on Monday. The stock has a market cap of $26.87 million, a P/E ratio of -3.45 and a beta of 2.08. Retractable Technologies has a fifty-two week low of $0.87 and a fifty-two week high of $1.34. The firm’s fifty day moving average price is $1.03 and its 200-day moving average price is $1.08. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. The firm had revenue of $6.03 million during the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.